Prostvac (Prostate Cancer) - Forecast and Market Analysis to 2022
Summary
GlobalData has released its new PharmaPoint Drug Evaluation report, “Prostvac (Prostate Cancer) - Forecast and Market Analysis to 2022”. The recent approvals of second-li
|
$ 3495
|
|
|
Gallbladder Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Gallbladder Cancer Global Clinical Trials Review, H2, 2012" provides data on the Gallbladder Cancer clinical trial scenario. This report pro
|
$ 2500
|
|
|
Testicular Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Testicular Cancer Global Clinical Trials Review, H2, 2012" provides data on the Testicular Cancer clinical trial scenario. This report provid
|
$ 2500
|
|
|
Fallopian Tube Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, H2, 2012" provides data on the Fallopian Tube Cancer clinical trial scenario. This r
|
$ 2500
|
|
|
Thyroid Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Thyroid Cancer Global Clinical Trials Review, H2, 2012" provides data on the Thyroid Cancer clinical trial scenario. This report provides elemen
|
$ 2500
|
|
|
Oral Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Oral Cancer Global Clinical Trials Review, H2, 2012" provides data on the Oral Cancer clinical trial scenario. This report provides elemental infor
|
$ 2500
|
|
|
Rectal Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Rectal Cancer Global Clinical Trials Review, H2, 2012" provides data on the Rectal Cancer clinical trial scenario. This report provides elemental
|
$ 2500
|
|
|
EpiCast Report: Colorectal Cancer Epidemiology Forecast to 2022
Summary
Colorectal cancer is the third most common cancer in men and second most common cancer in women. GlobalData’s epidemiologists expect the number of incident and prevalent ca
|
$ 3995
|
|
|
Cancer Anorexia – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Cancer Anorexia - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic develop
|
$ 2000
|
|
|
Intestinal Cancer – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Intestinal Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic dev
|
$ 2500
|
|
|
Metastatic Breast Cancer – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Metastatic Breast Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the t
|
$ 2500
|
|
|
Esophageal Cancer – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Esophageal Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic dev
|
$ 2500
|
|
|
Thyroid Cancer – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Thyroid Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic developme
|
$ 2000
|
|
|
Blood Cancer – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Blood Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development f
|
$ 2500
|
|
|
Liver Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Liver Cancer Global Clinical Trials Review, H2, 2012" provides data on the Liver Cancer clinical trial scenario. This report provides elemental in
|
$ 2500
|
|
|
Anal Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Anal Cancer Global Clinical Trials Review, H2, 2012" provides data on the Anal Cancer clinical trial scenario. This report provides elemental infor
|
$ 2500
|
|
|
Laryngeal Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Laryngeal Cancer Global Clinical Trials Review, H2, 2012" provides data on the Laryngeal Cancer clinical trial scenario. This report provides
|
$ 2500
|
|
|
Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012" provides data on the Kidney Cancer (Renal Cell Can
|
$ 2500
|
|
|
Lung Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Lung Cancer Global Clinical Trials Review, H2, 2012" provides data on the Lung Cancer clinical trial scenario. This report provides elemental infor
|
$ 2500
|
|
|
This Kalorama Information report – The Next Wave in Cancer Treatment--Kinase Inhibitors - is focused on a growing area of cancer treatment, kinase inhibitors. Several cancers are being treated with these newer therapies, which provide a focu...
|
$ 2500
|
|
|